Detalhe da pesquisa
1.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10445): 2709-2719, 2024 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843860
2.
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
Cell Mol Life Sci
; 81(1): 219, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758230
3.
Combination treatment with PD1/PDL-1 inhibitors for sarcomas: state of the art, next questions.
Curr Opin Oncol
; 36(4): 269-275, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726845
4.
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients.
Cytokine
; 177: 156542, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364458
5.
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Mol Cancer
; 22(1): 127, 2023 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559050
6.
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Lancet
; 400(10362): 1513-1521, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522207
7.
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
Oncologist
; 28(6): e425-e435, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869793
8.
ISG15 as a prognostic biomarker in solitary fibrous tumour.
Cell Mol Life Sci
; 79(8): 434, 2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864381
9.
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
Clin Orthop Relat Res
; 481(1): 107-116, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001000
10.
Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression.
Int J Mol Sci
; 24(1)2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614297
11.
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Cancer
; 128(1): 85-93, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643947
12.
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
J Surg Oncol
; 126(8): 1520-1532, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006054
13.
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcoma.
Future Oncol
; 18(30s): 5-11, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200935
14.
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes.
Future Oncol
; 18(30s): 13-22, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200954
15.
Experience with second-line trabectedin in daily clinical practice: case studies.
Future Oncol
; 18(30s): 23-32, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200932
16.
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas.
Int J Mol Sci
; 24(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614121
17.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910263
18.
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
Curr Opin Oncol
; 33(4): 329-335, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973551
19.
Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists.
J Surg Oncol
; 123(1): 12-23, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022754
20.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855868